在乳腺癌患者中,人环素诱导的心脏毒性的种族差异
相关实验视频
Updated: Jul 18, 2025

08:09
A Doxorubicin-induced Cardiomyopathy Model in Adult Zebrafish
Published on: June 7, 2018
9.8K
Swetha Balaji1, Antu K Antony1, Harry Tonchev1
1Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine, College of Medicine, University of Illinois at Chicago, Chicago, IL 60612, USA.
Biomedicines
|August 26, 2023
概括
乳腺癌治疗可能会导致心脏问题,特别是在少数群体患者中. 本综述探讨了导致心脏瘤学差异的遗传,临床和社会因素.
科学领域:
- 在瘤学瘤学.
- 心脏病学 心脏病学
- 健康差异 在健康上的差异
背景情况:
- 乳腺癌是全球最常见的癌症,治疗的进步降低了死亡率.
- 治疗的心血管影响对非转移性乳腺癌死亡率有显著的贡献.
- 这些心脏毒性影响不成比例地影响边缘化的种族/民族群体.
研究的目的:
- 审查乳腺癌患者心脏瘤学差异的遗传,临床和社会决定因素.
- 了解为什么与乳腺癌治疗相关的心脏毒性在少数群体中更为普遍.
- 确定导致心脏瘤学不平等结果的因素.
主要方法:
- 关于乳腺癌治疗心脏毒性研究的文献综述.
- 对遗传倾向和临床风险因素的分析.
- 检查影响少数群体患者的社会经济和医疗保健准入因素.
主要成果:
- 人环素 (例如,多克索鲁比) 会导致剂量依赖的心脏毒性 (心肌病,心力衰竭).
- 在少数群体中,风险因素 (肥胖,糖尿病,高血压) 的流行率更高.
- 粮食不安全和获得医疗保健等社会决定因素加剧了差距.
结论:
- 乳腺癌治疗心脏毒性差异是多因素的.
- 遗传和临床因素本身无法解释观察到的差异.
- 解决社会决定因素对于公平的心脏瘤护理至关重要.
相关概念视频
Cardiomyopathy IV: Restrictive Cardiomyopathy
12
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
12
Hazard Ratio
157
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
157
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
463
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
463
Cardiomyopathy I: Introduction and Classification
15
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
15
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Cardiovascular Drugs: Classification based on Therapeutic Indications
2.9K
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
2.9K

